Copyright Reports & Markets. All rights reserved.

Global Pharmacovigilance (PV) Outsourcing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Pharmacovigilance (PV) Outsourcing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Pharmacovigilance (PV) Outsourcing by Type
    • 1.3.1 Overview: Global Pharmacovigilance (PV) Outsourcing Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Pharmacovigilance (PV) Outsourcing Consumption Value Market Share by Type in 2023
    • 1.3.3 Contract Research Organizations (CROs)
    • 1.3.4 Business Process Outsourcing (BPOs)
  • 1.4 Global Pharmacovigilance (PV) Outsourcing Market by Application
    • 1.4.1 Overview: Global Pharmacovigilance (PV) Outsourcing Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Premarketing Clinical Trial
    • 1.4.3 Post-marketing Clinical Practice
    • 1.4.4 Other
  • 1.5 Global Pharmacovigilance (PV) Outsourcing Market Size & Forecast
  • 1.6 Global Pharmacovigilance (PV) Outsourcing Market Size and Forecast by Region
    • 1.6.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Pharmacovigilance (PV) Outsourcing Market Size by Region, (2019-2030)
    • 1.6.3 North America Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2019-2030)
    • 1.6.6 South America Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Accenture
    • 2.1.1 Accenture Details
    • 2.1.2 Accenture Major Business
    • 2.1.3 Accenture Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.1.4 Accenture Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Accenture Recent Developments and Future Plans
  • 2.2 C3i Solutions
    • 2.2.1 C3i Solutions Details
    • 2.2.2 C3i Solutions Major Business
    • 2.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.2.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 C3i Solutions Recent Developments and Future Plans
  • 2.3 Clintec
    • 2.3.1 Clintec Details
    • 2.3.2 Clintec Major Business
    • 2.3.3 Clintec Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.3.4 Clintec Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Clintec Recent Developments and Future Plans
  • 2.4 Covance
    • 2.4.1 Covance Details
    • 2.4.2 Covance Major Business
    • 2.4.3 Covance Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.4.4 Covance Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Covance Recent Developments and Future Plans
  • 2.5 Deloitte Touche Tohmatsu Limited
    • 2.5.1 Deloitte Touche Tohmatsu Limited Details
    • 2.5.2 Deloitte Touche Tohmatsu Limited Major Business
    • 2.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.5.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Deloitte Touche Tohmatsu Limited Recent Developments and Future Plans
  • 2.6 ELC Group
    • 2.6.1 ELC Group Details
    • 2.6.2 ELC Group Major Business
    • 2.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.6.4 ELC Group Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 ELC Group Recent Developments and Future Plans
  • 2.7 Ergomed
    • 2.7.1 Ergomed Details
    • 2.7.2 Ergomed Major Business
    • 2.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.7.4 Ergomed Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Ergomed Recent Developments and Future Plans
  • 2.8 iGATE Corporation
    • 2.8.1 iGATE Corporation Details
    • 2.8.2 iGATE Corporation Major Business
    • 2.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.8.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 iGATE Corporation Recent Developments and Future Plans
  • 2.9 iMED Global Corporation
    • 2.9.1 iMED Global Corporation Details
    • 2.9.2 iMED Global Corporation Major Business
    • 2.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.9.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 iMED Global Corporation Recent Developments and Future Plans
  • 2.10 IQVIA
    • 2.10.1 IQVIA Details
    • 2.10.2 IQVIA Major Business
    • 2.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.10.4 IQVIA Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 IQVIA Recent Developments and Future Plans
  • 2.11 MarksMan Healthcare
    • 2.11.1 MarksMan Healthcare Details
    • 2.11.2 MarksMan Healthcare Major Business
    • 2.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.11.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 MarksMan Healthcare Recent Developments and Future Plans
  • 2.12 Medpace Holdings
    • 2.12.1 Medpace Holdings Details
    • 2.12.2 Medpace Holdings Major Business
    • 2.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.12.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Medpace Holdings Recent Developments and Future Plans
  • 2.13 Novartis
    • 2.13.1 Novartis Details
    • 2.13.2 Novartis Major Business
    • 2.13.3 Novartis Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.13.4 Novartis Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Novartis Recent Developments and Future Plans
  • 2.14 Oracle Corporation
    • 2.14.1 Oracle Corporation Details
    • 2.14.2 Oracle Corporation Major Business
    • 2.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.14.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Oracle Corporation Recent Developments and Future Plans
  • 2.15 Parexel
    • 2.15.1 Parexel Details
    • 2.15.2 Parexel Major Business
    • 2.15.3 Parexel Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.15.4 Parexel Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Parexel Recent Developments and Future Plans
  • 2.16 PharmInvent
    • 2.16.1 PharmInvent Details
    • 2.16.2 PharmInvent Major Business
    • 2.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.16.4 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 PharmInvent Recent Developments and Future Plans
  • 2.17 PrimeVigilance
    • 2.17.1 PrimeVigilance Details
    • 2.17.2 PrimeVigilance Major Business
    • 2.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.17.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 PrimeVigilance Recent Developments and Future Plans
  • 2.18 Pure Drug Safety
    • 2.18.1 Pure Drug Safety Details
    • 2.18.2 Pure Drug Safety Major Business
    • 2.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.18.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Pure Drug Safety Recent Developments and Future Plans
  • 2.19 Sciformix
    • 2.19.1 Sciformix Details
    • 2.19.2 Sciformix Major Business
    • 2.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.19.4 Sciformix Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Sciformix Recent Developments and Future Plans
  • 2.20 SIRO Clinpharm
    • 2.20.1 SIRO Clinpharm Details
    • 2.20.2 SIRO Clinpharm Major Business
    • 2.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.20.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.20.5 SIRO Clinpharm Recent Developments and Future Plans
  • 2.21 Symogen
    • 2.21.1 Symogen Details
    • 2.21.2 Symogen Major Business
    • 2.21.3 Symogen Pharmacovigilance (PV) Outsourcing Product and Solutions
    • 2.21.4 Symogen Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.21.5 Symogen Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Pharmacovigilance (PV) Outsourcing Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Pharmacovigilance (PV) Outsourcing by Company Revenue
    • 3.2.2 Top 3 Pharmacovigilance (PV) Outsourcing Players Market Share in 2023
    • 3.2.3 Top 6 Pharmacovigilance (PV) Outsourcing Players Market Share in 2023
  • 3.3 Pharmacovigilance (PV) Outsourcing Market: Overall Company Footprint Analysis
    • 3.3.1 Pharmacovigilance (PV) Outsourcing Market: Region Footprint
    • 3.3.2 Pharmacovigilance (PV) Outsourcing Market: Company Product Type Footprint
    • 3.3.3 Pharmacovigilance (PV) Outsourcing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Pharmacovigilance (PV) Outsourcing Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Pharmacovigilance (PV) Outsourcing Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Pharmacovigilance (PV) Outsourcing Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Pharmacovigilance (PV) Outsourcing Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Pharmacovigilance (PV) Outsourcing Consumption Value by Type (2019-2030)
  • 6.2 North America Pharmacovigilance (PV) Outsourcing Consumption Value by Application (2019-2030)
  • 6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Country
    • 6.3.1 North America Pharmacovigilance (PV) Outsourcing Consumption Value by Country (2019-2030)
    • 6.3.2 United States Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Pharmacovigilance (PV) Outsourcing Consumption Value by Type (2019-2030)
  • 7.2 Europe Pharmacovigilance (PV) Outsourcing Consumption Value by Application (2019-2030)
  • 7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country
    • 7.3.1 Europe Pharmacovigilance (PV) Outsourcing Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 7.3.3 France Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region
    • 8.3.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Consumption Value by Region (2019-2030)
    • 8.3.2 China Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 8.3.5 India Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Pharmacovigilance (PV) Outsourcing Consumption Value by Type (2019-2030)
  • 9.2 South America Pharmacovigilance (PV) Outsourcing Consumption Value by Application (2019-2030)
  • 9.3 South America Pharmacovigilance (PV) Outsourcing Market Size by Country
    • 9.3.1 South America Pharmacovigilance (PV) Outsourcing Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country
    • 10.3.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Pharmacovigilance (PV) Outsourcing Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Pharmacovigilance (PV) Outsourcing Market Drivers
  • 11.2 Pharmacovigilance (PV) Outsourcing Market Restraints
  • 11.3 Pharmacovigilance (PV) Outsourcing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Pharmacovigilance (PV) Outsourcing Industry Chain
  • 12.2 Pharmacovigilance (PV) Outsourcing Upstream Analysis
  • 12.3 Pharmacovigilance (PV) Outsourcing Midstream Analysis
  • 12.4 Pharmacovigilance (PV) Outsourcing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Pharmacovigilance (PV) Outsourcing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Pharmacovigilance (PV) Outsourcing industry chain, the market status of Premarketing Clinical Trial (Contract Research Organizations (CROs), Business Process Outsourcing (BPOs)), Post-marketing Clinical Practice (Contract Research Organizations (CROs), Business Process Outsourcing (BPOs)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmacovigilance (PV) Outsourcing.
    Regionally, the report analyzes the Pharmacovigilance (PV) Outsourcing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmacovigilance (PV) Outsourcing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Pharmacovigilance (PV) Outsourcing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmacovigilance (PV) Outsourcing industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Contract Research Organizations (CROs), Business Process Outsourcing (BPOs)).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmacovigilance (PV) Outsourcing market.
    Regional Analysis: The report involves examining the Pharmacovigilance (PV) Outsourcing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmacovigilance (PV) Outsourcing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Pharmacovigilance (PV) Outsourcing:
    Company Analysis: Report covers individual Pharmacovigilance (PV) Outsourcing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmacovigilance (PV) Outsourcing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Premarketing Clinical Trial, Post-marketing Clinical Practice).
    Technology Analysis: Report covers specific technologies relevant to Pharmacovigilance (PV) Outsourcing. It assesses the current state, advancements, and potential future developments in Pharmacovigilance (PV) Outsourcing areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmacovigilance (PV) Outsourcing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Pharmacovigilance (PV) Outsourcing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Contract Research Organizations (CROs)
    Business Process Outsourcing (BPOs)
    Market segment by Application
    Premarketing Clinical Trial
    Post-marketing Clinical Practice
    Other
    Market segment by players, this report covers
    Accenture
    C3i Solutions
    Clintec
    Covance
    Deloitte Touche Tohmatsu Limited
    ELC Group
    Ergomed
    iGATE Corporation
    iMED Global Corporation
    IQVIA
    MarksMan Healthcare
    Medpace Holdings
    Novartis
    Oracle Corporation
    Parexel
    PharmInvent
    PrimeVigilance
    Pure Drug Safety
    Sciformix
    SIRO Clinpharm
    Symogen
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Pharmacovigilance (PV) Outsourcing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Pharmacovigilance (PV) Outsourcing, with revenue, gross margin and global market share of Pharmacovigilance (PV) Outsourcing from 2019 to 2024.
    Chapter 3, the Pharmacovigilance (PV) Outsourcing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharmacovigilance (PV) Outsourcing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmacovigilance (PV) Outsourcing.
    Chapter 13, to describe Pharmacovigilance (PV) Outsourcing research findings and conclusion.

    Buy now